High Palcebo peaks in sample chromatogram

Discussions about HPLC, CE, TLC, SFC, and other "liquid phase" separation techniques.

2 posts Page 1 of 1
Hi all,
It has been quite long since my last post!!. I have a question,
In our drug product related substance chromatogram there are some peaks observed sample as well as in placebo. However, the peak response is higher in the sample (40 to 50% higher). Should we have to report it? Anybody faced such issues?. How to go ahead about that?

Appreciate valid responses,

Thanks
Vijayak
That strongly implies that your sample contains peaks that co-elute with peaks from the placebo. I'm sorry to be the bearer of bad news, but at a minimum, that "excess" area should be reported. If it represents a sufficient area to be identified, I would recommend that you develop an orthogonal method to separate what is sample-related from the placebo.
-- Tom Jupille
LC Resources / Separation Science Associates
tjupille@lcresources.com
+ 1 (925) 297-5374
2 posts Page 1 of 1

Who is online

In total there are 13 users online :: 1 registered, 0 hidden and 12 guests (based on users active over the past 5 minutes)
Most users ever online was 200 on Fri Nov 10, 2017 4:15 pm

Users browsing this forum: Google [Bot] and 12 guests